当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

A Comparison of the Types of Public and Private Dental Benefit Payers for the Treatment of Children's and Adolescent's Permanent Teeth Requiring Root Canal Therapy and the Results

Nihan Gence

The FDI is working on a tool that will include patient-reported outcome measures (PROMs) in the overall evaluation of endodontic treatment outcomes. Various clinical and radiographic criteria have traditionally been used to determine the outcome of endodontic treatment. However, the impact of treatment on a patient’s oral health-related quality of life (OHRQoL) is not addressed by these parameters. OHRQoL, a crucial PROM, can be used to understand treatment outcomes from a patient-centered perspective, enhancing communication between clinicians and patients and directing decision-making. The purpose of this narrowed-down review is to compare the OHRQoL of patients who had surgical endodontic treatment versus nonsurgical root canal treatment, with a particular focus on the minimal important difference (MID; the minimum changes in an outcome instrument’s score that a patient needs to see a change that is clinically significant in their OHRQoL and/or oral condition) as well as the methods used to figure it out. According to the current evidence, patients who require root canal treatment have lower OHRQoL than those who do not. As a result,the literature suggests that either nonsurgical or surgical endodontic treatment improves OHRQoL. However, due to the wide range of study methods, neither MID recommendations nor high-confidence conclusions can be drawn. Therefore, clinical studies with appropriate follow-up times and baseline measurements are required. Even though there are many outcome studies in the literature, more research is needed on PROMs, especially in relation to the MID. The MID will make it easier to comprehend changes in outcome scores from the patients’ perspective, allowing for better clinical practice decision-making.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。